Description
Product Properties
|
Property Name |
Property Details |
|
Alternative Names |
CEA, CEACD66e, CD66e, CEACAM-5 |
|
Species |
Human |
|
Expression Sequence |
Pro145-Pro322 |
|
Accession |
P06731-1 |
|
Tag |
C-His |
|
Expression System |
HEK293 |
|
Molecular Weight |
Predicted MW: 20.66 kDa → Glycosylation shifts to 50-70 kDa (SDS-PAGE) |
|
Purity |
>95% (SDS-PAGE & HPLC) |
|
Endotoxin |
<1.0 EU/μg (LAL method) |
|
Formulation |
Liquid solution in 0.22 μm filtered PBS (pH 7.4) |
|
Appearance |
Liquid |
Features
High purity, high activity, low endotoxin, high batch-to-batch consistency
Storage
Store at -85 to -65°C upon receipt; stable for 1 year.
Avoid repeated freeze-thaw cycles.
Critical handling protocol:Centrifuge vial before opening.Aliquot into single-use portions.Store aliquots at -80°C.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.